Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-26 @ 3:17 PM
NCT ID:
NCT07347535
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years (adults capable of giving consent)
* Capacity to consent. The subjects are able to understand the information provided and give their written consent.
* Belonging to one of the following cohorts:
* Endurance athletes: at least 3× per week ≥ 60 minutes of intensive endurance training (e.g., running, cycling, swimming)
* Strength athletes: at least 3× per week ≥ 60 minutes of intensive strength training without additional endurance training
* Healthy control subjects: less than 2× per week \< 30 minutes of physical activity, no known vascular diseases
* PAD patients: diagnosed peripheral arterial occlusive disease in Fontaine stage I or IIa Women of childbearing age with or without contraception may participate, as there are no risks of harm to the fetus.
* Consent to pseudonymized data collection and storage in accordance with the GDPR.
Exclusion Criteria:
* Age over 75 years
* Minors (Age \< 18)
* safety concerns on the part of the study physician, e.g., in the case of of: physical, mental or psychiatric illnesses, acute or chronic conditions that could jeopardise safety or data quality
* Taking medications that could affect physical performance or physiological measurements (e.g., heart rate, oxygen uptake).
* Pregnancy with known risks or complications (participation is possible in principle, but subject to individual medical review).
* Refusal to participate or lack of informed consent.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT07347535
Study Brief:
Protocol Section:
NCT07347535